shiv
●    

2006-01-25 07:39
(6722 d 09:33 ago)

Posting: # 60
Views: 16,355
 

 ANVISA Approval [Regulatives / Guidelines]

BE studies for Brazil is after ANVISA approval
H_Rotter
★    

Germany,
2006-01-25 13:31
(6722 d 03:41 ago)

@ shiv
Posting: # 62
Views: 12,508
 

 ANVISA Approval

Dear shiv,

...and what is your question? :confused:
shiv
●    

2006-01-27 09:14
(6720 d 07:58 ago)

@ H_Rotter
Posting: # 66
Views: 12,603
 

 ANVISA Approval

Dear Rotter,

Conducting BE studies for brazil market is only after anvisa inspection and approval or after the study, submission of documents and inspection process (Like FDA)?
H_Rotter
★    

Germany,
2006-01-27 15:00
(6720 d 02:12 ago)

@ shiv
Posting: # 68
Views: 12,439
 

 ANVISA Approval

Dear shiv,

it's different from the FDA.
The center(s) performing the study must follow ANVISA's rules (http://www.anvisa.gov.br/eng/legis/resol/103_03rdc_e.htm), must be inspected (http://www.anvisa.gov.br/eng/bio/form_bio.doc), and renew their status anually (http://www.anvisa.gov.br/eng/bio/form_renewal.rtf). After approval of the protocol by the local IEC, the study may be performed.

Only if your protocol deviates from ANVISA's standards (e.g. if you want to perform at multiple dose study in order to reduce variability for HVDs), I would strongly recommend contacting them before.

good luck!
Hermann Rotter
UA Flag
Activity
 Admin contact
23,059 posts in 4,841 threads, 1,665 registered users;
31 visitors (0 registered, 31 guests [including 5 identified bots]).
Forum time: 18:12 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5